首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1575748

全球膽紅素測量儀市場 - 2024-2031

Global Bilirubin Meters Market - 2024-2031

出版日期: 2024年10月22日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球膽紅素計量儀市場規模達1.081億美元，預計2031年將達到1.364億美元，2024-2031年預測期間複合年成長率為10.16%。

膽紅素計是一種測量患者血液中膽紅素含量的裝置。是診斷和治療新生兒黃疸的重要工具。它通常使用分光光度法來測量膽紅素水平，這有助於診斷和監測黃疸、肝臟疾病和溶血性疾病等疾病。

膽紅素測定儀可用於攜帶式和實驗室環境，為臨床決策提供重要資料。通常用於新生兒評估黃疸，確定其嚴重程度以及是否需要治療，例如光療。它們有助於評估和分析膽紅素代謝，並有助於診斷肝臟疾病，如肝炎、肝硬化和其他代謝性疾病。

市場動態：

驅動程式和限制

膽紅素測定儀的技術進步

膽紅素測定儀的技術進步預計將推動市場成長。增強的測量技術，例如增強的分光光度法和多波長分析，可以產生更一致的結果，從而增強對這些儀器的信任。非侵入性膽紅素檢測儀利用光感測器透過皮膚監測膽紅素水平，預計將提高篩檢的舒適度和可及性，尤其是對於嬰兒。

小型化和使用者介面設計的進步帶來了更便攜、易於使用的設備，醫療保健專業人員只需很少的指導即可操作這些設備，從而可以廣泛使用。更快的分析時間提高了臨床環境中的工作流程效率，從而可以快速做出診斷和治療決策。技術進步可以降低製造成本，使醫療機構的膽紅素測定儀更便宜，並提高市場佔有率。因此，上述因素預計將推動市場成長。

設備成本高

醫院和診所，特別是中低收入地區的醫院和診所，可能需要幫助購買昂貴的設備。這可能會限制他們投資新技術的能力，從而阻礙新技術的採用。如果有更便宜的選擇，未來的買家可能會選擇它們，從而使高價產品難以競爭。這可能會導致優質產品的市場佔有率下降。

The bilirubin meter is a device that measures the amount of bilirubin in a patient's blood. It is an important tool in the diagnosis and treatment of neonatal jaundice. It typically uses spectrophotometric methods to measure bilirubin levels, which aids in the diagnosis and monitoring of illnesses like jaundice, liver disease, and hemolytic disorders.

Bilirubin meters can be found in both portable and laboratory settings, giving essential data for clinical decision-making. Commonly used in neonates to assess jaundice, determining its severity and the need for treatment, such as phototherapy. They help in evaluating and analyzing bilirubin metabolism and help in diagnosing liver diseases such as hepatitis, cirrhosis, and other metabolic diseases.

Market Dynamics: Drivers & Restraints

Technological advancement in bilirubin meters

Technological advancements in bilirubin meters are expected to drive the market growth. Enhanced measuring techniques, such as enhanced spectrophotometry and multi-wavelength analysis, produce more consistent results, boosting trust in these instruments. Non-invasive bilirubin meters, that utilize light sensors to monitor bilirubin levels via the skin are expected to improve the comfort and accessibility of screening, especially for babies.

Advances in miniaturization and user interface design have led to more portable, simple-to-use devices that can be operated by healthcare professionals with minimal instruction, allowing for widespread use. Faster analysis times improve workflow efficiency in clinical environments, allowing for rapid diagnostic and treatment decisions. Technological advancements can result in lower manufacturing costs, making bilirubin meters cheaper for healthcare facilities and boosting market share. Thus, the above factors are expected to drive the market growth.

High cost of the devices

Hospitals and clinics, particularly in low- and middle-income areas, may need help with funding costly equipment. This can limit their ability to invest in new technologies, impeding their adoption. If cheaper options exist, buyers in the future may choose them, making it difficult for high-priced products to compete. This could result in a lower market share for premium products.

Segment Analysis

The global bilirubin meters market is segmented based on product type, age group, indication, end-user, and region.

Transcutaneous segment is expected to dominate the market share

The transcutaneous segment holds a significant position in the global market share and is expected to continue throughout the forecast period. These gadgets are non-invasive, accurate, cost-effective, and time-saving.

Moreover, transcutaneous devices are used to screen jaundice in newborn babies without a needle prick, and they are becoming more popular as an alternative to serum bilirubin analyzers. Transcutaneous bilirubinometers serve as a valid screening method for identifying neonates who require total serum bilirubin measurement before phototherapy.

Transcutaneous meters produce immediate results, allowing for more rapid clinical decision-making and rapid action in situations like as jaundice. Due to their efficiency and portability, these devices are gaining demand and are expected to hold a significant position in the market share.

Geographical Analysis

North America is expected to hold a significant position in the bilirubin meters market share

North America accounted for the highest revenue share. The increasing prevalence of liver diseases, the rising geriatric population, rising healthcare spending, well-established infrastructure, and technological advancements in bilirubin meters are factors expected to boost the market in the forecast period.

For instance, according to the Children's Hospital of Philadelphia in 2024, it is stated that hyperbilirubinemia is very common, affecting approximately 60 percent of term newborns and 80 percent of premature babies develop jaundice. The increasing number of hyperbilirubinemias requires continuous evaluation and analysis of the quantity of bilirubin, thus increasing the demand for the devices. Thus, the above factors are expected to hold the region's market growth.

Market Segmentation

By Product Type

Bench-top
Transcutaneous

By Age Group

Neonates
Adults
Others

By Indication

Hepatitis
Jaundice
Others

By End-User

Hospitals
Clinics
Diagnostic Centers
Others

By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the market include Delta Medical International Ltd, Mennen Medical Ltd, Ningbo David Medical Device Co. Ltd., Micro Lab Instruments, Zeal Medical, Dragerwerk AG & Co. KGaA, Labtron Equipment Ltd, Korrida Medical Systems, GPC Medical Ltd and Braun & Co. Limited. among others.

Why Purchase the Report?

To visualize the global bilirubin meters market segmentation based on product type, age group, indication, end-user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of bilirubin meters market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global bilirubin meters market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Age Group
3.3. Snippet by Indication
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological advancement in bilirubin meters
- 4.1.2. Restraints
  - 4.1.2.1. High cost of the devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Bench-top*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Transcutaneous

7. By Age Group

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 7.1.2. Market Attractiveness Index, By Age Group
7.2. Neonates*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Adults
7.4. Others

8. By Indication

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 8.1.2. Market Attractiveness Index, By Indication
8.2. Hepatitis*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Jaundice
8.4. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Diagnostic Centers
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
  - 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  - 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  - 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.3.1. The U.S.
  - 10.2.3.2. Canada
  - 10.2.3.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
  - 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  - 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.4.1. Germany
  - 10.3.4.2. UK
  - 10.3.4.3. France
  - 10.3.4.4. Italy
  - 10.3.4.5. Spain
  - 10.3.4.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
  - 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  - 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.4.1. Brazil
  - 10.4.4.2. Argentina
  - 10.4.4.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
  - 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  - 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.4.1. China
  - 10.5.4.2. India
  - 10.5.4.3. Japan
  - 10.5.4.4. South Korea
  - 10.5.4.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
  - 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  - 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Delta Medical International Ltd*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Mennen Medical Ltd
12.3. Ningbo David Medical Device Co. Ltd.
12.4. Micro Lab Instruments
12.5. Zeal Medical
12.6. Dragerwerk AG & Co. KGaA
12.7. Labtron Equipment Ltd
12.8. Korrida Medical Systems
12.9. GPC Medical Ltd
12.10. Braun & Co. Limited

LIST NOT EXHAUSTIVE